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HISTORICAL NOTES
CoronaryArteryThrombosis:Historical Aspects
JAMES E. MULLER, MD, FACC
Boston. Massachusetts
There is intense scientificinterestin the possibility that
the acuteadministrationf a fibrinolytic agent might be
of benefit to patients with acute myocardial infarction.
This hypothesis, which will soon be tested in a major
trialby the NationalHeart,Lung, and BloodInstitute,
has emerged from a confluence of advances in three
areas: increased knowledge about the role of thrombosis
in myocardialinfarction,the development of fibrinolytic
Insightsgainedfrom coronaryarteriographyduring acute
myocardialinfarctionand preliminaryresults from the in-
tracoronaryadministrationoffibrinolyticagents leave little
doubtthatcoronaryarterythrombosisoccursduring acute
myocardialinfarction.Dramaticangiogramshave now been
obtainedthat showpartiallylysed clotsbreakingloose and
movingdistallyin acoronaryartery.Directobservationof
thevessels,when coronaryarterybypasssurgeryhas been
performeduringtransmuralmyocardialinfarction,also re-
veals that athrombusis presentin mostcases.
From this vantagepointand the insight intoc ronary
thrombosisthat itprovides,it isfascinatingto review the
tortuoushistoryoftherecognitionofcoronaryartery throm-
bosis. Ourunderstandingof the pathophysiologyof myo-
cardialinfarctionhas advancedmarkedly,but unsteadily,
in thiscentury.The importanceof coronarythrombosisin
myocardialinfarctionwas firstemphasizedbetween 1910
and 1940,increasinglyquestionedfrom 1940 to 1960 and
is beingreemphasizedatpresent.
EarlyUnderstandingof Thrombosis
The formationof a clot from liquidblood,an obvious
process,wasrecognizedevenbefore400 B.C. Hippocrates
andAristotleknewthatbloodcouldcoagulate,butattributed
it tocooling(I). Otherscontendedthatclottingwascaused
by cessationof natural flow. Theunderstandingof the pro-
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agents and the recognitionthatischemic myocardial tis-
sue might be salvaged from necrosis by timely reper-
fusion.Examinationof themannerin which these areas
of knowledge developed andinteractednot only illu-
minates our path to this specifictherapeuticpossibility,
but alsodemonstratestheindirectandstutteringmanner
in whichimportantnew ideas often evolve.
cessremainedrelativelyprimitiveuntilWilliamHewson(2)
beganthe firstscientificstudies ofclottingin 1772. In the
same year, WilliamHeberden(3)published"SomeAccount
of aDisorderof theBreast,"the firstcompletedescription
of thesymptomsof ischemicheartdisease.This majorclin-
ical achievementshed no light onpathophysiology,how-
ever,because Heberdenwas not aware thatnginalpains
originatedfrom theheart,let alone that they might be due
to coronaryobstruction.His friend,EdwardJenner(4),
wrote toHeberden,describingwhat may have been athrom-
bus in thecoronaryarteryofa person who died with angina
pectoris,but theconnectionof thrombosiswith symptoms
remainedobscure.
AlthoughancientEgyptiansand thephysiciansof clas-
sical antiquitybelievedthatobstructionof a vesselcould
causedisease(5), it was not until theextraordinarywork
ofRudolfVirchow (6) that thepathologiconceptthat dis-
ease could becausedby thrombosiswas firmlyestablished.
Although Virchow did notcommenton coronarythrom-
bosis,he developedthe conceptualframeworkfor recog-
nition of theoccurrenceofthrombosisin anyorgan.In 1846,
he describedtheocclusionof apulmonaryartery bythrom-
bosis; he laterdescribedthrombosisand embolismin the
liver andspleen.
Recognition of Thrombosis in the
CoronaryArtery
AfterVirchow'sfindings, there werenumerouspatho-
logic descriptionsof coronaryarterythrombosis.In 1866,
Vulpian(7) describeda caseof ruptureof the heart that
coincidedwith an oldbloodclot in oneof the coronary
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Table1. Prevalence of Thrombotic Coronary ArteryOcclUSIOn
in Groups of Patients Stated to Have Died FromMy cardial
Infarction*
thrombosis wasgreaterin patients who died late after the
onset of symptoms than in those who died earl y. This ob-
servation formed the basis for the view that the thrombus
was aresult ratherthan acause of the infarction. By the
1960s. thesequestions concerning the roleof coronary
thrombosis were sufficient tocloud the issue and ampen
enthusiasm for the use of fibrinolytic agents,whichby then
had becomeavailable for routine use ( 17, 18). Information
about the presenceof thrombosis became so confused that
in 1969, Mitchell (19) was able to construct a table (Table
I) that showed areportedprevalenc e of coronary occlu sion
varyingbetween0 and 96% in variousseriesof patients
withpresumedmyocardialinfarction .
The reasonsfor confusionwerediscussedin 1973 in a
workshopsponsoredby the NationalInstitutesofHealthon
"CoronaryThrombosisin MyocardialInfarction"(20) . The
varyingincidenceof thrombosis in myocardialinfarction
could,in part , be explained by inclusion insomeserie s of
patient s who died asuddenarrhythmic deathwithoutin-
farction . Severalstudies were diluted with these unrelated
cases.Otherseriesincludedmany patients with subendo-
cardial infarction, who have a low incidenceofthrombosis;
also, in some case s the methods used topreparetissues for
pathologic study may have dislodged thethrombus.
The view thathrombosis results frominfarctionwas
count ered by two observations. First, there is generally some
lengthof uninvolvedartery between then croticarea and
theintracoronarythrombus; second, vesse ls in thecenter of
the necroticarea , where anythrombogenic force sof in-
farction might beexpectedto be maximal , aregenerally
free ofthrombus. Theconclusionofthe work shop was that
"asubstantial bodyofknowledge supports theclassiccon-
cept of theprimaryroleof thrombosis in thepathogenesis
of infarction."
arteries. Shortl ythereafter, Payne(8) reportedon a patient
whose rightcoronaryartery''containeda dark-redclot and
wascompletelyblocked."
Attentionto coronary thrombosis was limitedprimarily
to pathologists untilpublicationby Hammer(9) in 1878of
.. A CaseofThromboticOcclusionofOne of theCoronary
Arteries of theHeart."This report isgenerally acknowl-
edgedto be the firstdiagnosisof coronaryocclusionmade
duringthe lifeofa patient.Thereis somedebate, however,
as towhethertheocclusion resultedfromprimarycoronary
thrombosis or fromembolismofa vegetationassociatedwith
subacutebacterialendocarditis (10 ).
By 1880, allpertinentclinicalandanatomicinformation
had beenassembledto identifythe conditionof coronary
thrombosis and theclinicalpictureofmyocardialinfarction.
However, theconventionalbelie f at the time was that cor-
onaryocclusioninevitablyled to sudden death . In 1910 the
Russian physicians,Obraztsovand Strazhesko(II) , com-
bined theclinicaldescriptionsof chest pain with eventual
autopsy findingsofcoronarythrombosis to firmly establi sh
the existenceofnonfatalcoronaryocclusion . In the United
StatesHerrick( 12) in 1912 publi shed his well known article ,
"Clinical Features of SuddenObstructionof theCoronary
Arteries." Theseearlydescriptions of myocardialinfarction
focused on"obstruction"ofthecoronaryarteries.Indeed,
when theconditiondescribedby Herrickbecamewidely
accepted in the 1930s , it was generallyc lled"coronary
thrombosis."
Controversyregardingtheimportanceofcoronarythrom-
bosis intensified in 1939 with thepublicationby Friedberg
and Horn (13)of an articleentitled," Acute Myocardial
Infarctionot due toCoronaryObstruction."Theirfindings
resulted fromimprovedrecognitionof myocardialinfarcts
with theidentificationofcasesof subendocardialinfarction.
In a seriesof 1,000consecutiveautopsies,91 cases had
signsofmyocardialnecrosis.In 28 (31%) of thecases,there
was no evidenceofcoronarythrombosis. It was speculated
that in some cases theinfarctionwas relatedto an excess
of myocardialoxygendemandoversupply which was lim-
ited byatherosclerosis.In othercases, it was thought that
coronary spasmighthave cau sed the infarction.Friedberg
and Hom notedthat theclinicaland electrocardiographic
signsoftheconditionareproduced bymyocardialnecrosis
that mayormay not beaccompaniedby coronarythrom-
bosis. The ythereforeconcludedthat " it wouldappearmore
accurateto employthe clinicaldiagnosis myocardial in-
farction than coronary thrombosis ." The caseagainst
thrombosiwaslatermade with increasing effectiveness by
other pathologists(14-16). A majorreason for theconclu-
sion thatthrombosishad no role in thetiology of myo-
cardial infarction was the absenceof thrombiin many pa-
tientsdyingof presumedmyocardial infarction.
Coronarythrombosis:a resultratherthana causeof
infarction?It was assertedthat thefrequencyofcoronary
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Treatment of Coronary Thrombosis
Knowledgeof anticoagulantand fibrinolytic therapy ac-
cumulatedindependentlyof thecontinuingdebate on the
role ofcoronarythrombosisin infarction.Anticoagulant
agents,which canpreventhrombusformation but have no
effecton anestablishedthrombus,have been used exten-
sively ininfarctionwith littleapparenteffect. Theconsensus
has been that these agents may have a small beneficial effect,
achievedby preventingthromboticomplicationsof infarc-
tion, but do not affect the course of the infarctitself(21,22).
Fibrinolyticagents,which have theremarkableability to
producelysis of athrombusand therebyreestablishcoronary
bloodflow, offergreaterpotential benefit than do antico-
agulantagents.
The existenceof ahumoralfactor in human urine that
could bring about thedissolutionof fibrin clots was first
reportedin 1885 by Sahli (23). This factor was later ex-
tracted,purified and given the name of"urokinase."In
1933, Tillett andGarner(24) identified asimilarbut distinct
factorproducedby hemolyticstreptococciand now known
as "streptokinase."
Intravenous streptokinase therapy. In 1965,Fletcher
et al.reportedthaturokinasecould be safelyadministered
to human beings and could produce athrombolyticstate.
In 1966, a major trial wascompletedwhich examinedthe
value ofstreptokinasetherapyfor acutemyocardialinfarc-
tion (18). A total of 297patientsreceivedstreptokinase
intravenouslywhile 261receivedanticoagulantagents. The
40 daymortalityrate was 14.1% in thestreptokinasegroup
versus 21% in theanticoagulantgroup.Althoughthese re-
sultsappearedpromising,there weremethodologicprob-
lems with the study and severalsubsequentstudies did not
havesimilarresults. The status ofthrombolytictherapy for
acutemyocardialinfarctioncoincidedwith the general status
of suchtherapyforthrombosisin any organ assummarized
in 1969 byFletcher(25):
.. Although clinical research has been mostencouraging,the place of
thrombolytic agents10 the therapeuticarmamentanumremains
essennallyundefined. Despite conclusive evidence that these
agents, when acting on fresh thrombi or emboli, produce 'in
vivo' thrombolysis,we are now faced With the problem of
deterrnming the clinical benefits of restoring blood supply to
organs and tissues that have beend p vedof it for an often
unknownpenodof rime."
Salvage of Ischemic Myocardium
In 1971,experimentalevidencewaspresentedindicating
that benefits could beobtainedby restoringblood flow to
ischemicmyocardium(26,27).Theconceptwasintroduced
that theamountof myocardiumthatbecomesnecrotic after
coronaryocclusionis not fixed, but can be reduced by a
numberof interventions,particularlythe timely removal of
a ligation orobstructionwithsubsequentrestorationof flow.
It wasdemonstratedin animals that suchreperfusioncould
lead to salvage of asubstantialmount ofmyocardium(28).
Acceptanceof theconceptof limitation ofinfarctsize,
the advanced state ofc ronaryangiography,theavailability
of high quality fibrinolytic agents and thebeli fthatcoro-
narythrombosiswas the cause ofmyocardialinfarctionled
severalinvestigatorsto instillstreptokinasedirectlyinto a
coronaryartery duringinfarction.Chazovet al. (29) and
Rentrop et al. (30) clearlydemonstratedthatcoronarypat-
ency could bereestablishedin such a manner.Cardiovas-
cular surgeons,using the same rationale oflimitationof
infarct size, havep rformedcoronaryarterybypasssurgery
duringmyocardialinfarction withapparentsafety (31). Be-
cause of a lack ofcontrolledstudies,it is not knownwhether
thisinterventionactually salvagesmyocardium.A valuable
byproductof emergencysurgery has been direct visual con-
firmation of theimportantrole ofcoronarythrombosisin
myocardialinfarction.
Conclusion
The major riddle of the role ofcoronarythrombosisin
infarctionhas been solved:thrombosisis aprominentcaus-
ative factor in the vastmajorityof cases oftransmuralin-
farction.It is thuslegitimateto revive usage of the diagnosis
of "coronarythrombosis"for manypatients.In a patient
with a freshocclusion,thisdiagnosismay be more accurate
than "myocardialinfarction"becauseimmediaterestora-
tion of flow could lead to salvage of all the ischemic myo-
cardiumwithoutinfarction.
Several questions remain concerning coronary throm-
bosis. From thestandpointof etiology,there are few data
regardingthe cause of thethrombosisitself. Is itcausedby
coronaryspasm, plateletabnormalities,coronaryathero-
sclerosisor othercurrentlyunknownfactors? In regard to
therapy,it is importanto know the relative merits ofin-
travenous versusintracoronary administrationof a fibrin-
olytic agent. What is the maximal time after onset of symp-
toms at whichreperfusionwith athrombolyticagent can be
of value?Finally,are there beneficialeffectson mortality
and morbiditythat can beachieved,and if so, of what
magnitude?
Until now, the history ofcoronarythrombosishas been
one ofclarificationof pathophysiologyanddevelopmentof
potential therapy. The task at present is toevaluatethe
effectivenessof thrombolytictherapyagainsthethrombus,
which is nowacceptedas a major causal factor in acute
myocardialinfarction.
I am grateful to Peter Stone. MD and Zoltan Turi , MD for review of the
manuscript and to Deidre Bernard for assistance10 It, preparation.
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